
Do you have any questions? (088) 2080369 - 2345622 Pharmacy_QAAU@pharm.aun.edu.eg
Under the auspices of Prof. Dr. / Ahmed El Menshawy - Acting President of the University, and Dr. / Ahmed Mohamed Abdel Mawla - Dean of the Faculty and Acting Vice President of the University for Education and Student Affairs and under the supervision of Dr. / Hassan Refaat Hassan - Vice Dean for Education and Student Affairs and Prof. Dr. / Mohamed Mahmoud Abdel Latif - Vice Dean for Community Service and Environmental Development Affairs and Dr. / Nermin El-Iraqi - Assistant Professor in the Department of Pharmaceutics and Director of the Scientific Association for Students of the Faculty of Pharmacy Students of the Scientific Association for Students of the Faculty of Pharmacy, Assiut University (Assuit EPSF) organized a medical convoy and distribution 150 blankets for the most needy groups in the village of Bani Shuqair in Manfalut - Assiut
This was done on Friday 12/23/2022 AD

Under the auspices of Prof. Dr. / Ahmed El-Minshawy - Acting President of the University and Prof. Dr. / Ahmed Mohamed Abdel-Mawly - Dean of the Faculty and Acting Vice-President of the University for Education and Student Affairs, and within the framework of final preparations for the start of the exams for the first semester of the academic year 2022/2023 and It is scheduled to start on Tuesday, corresponding to 12/27/2022. Prof. Dr. Hassan Refaat Hassan - Vice Dean for Education and Student Affairs, accompanied by Mr. / Abdel Hafez Ali Abdel Hafez - Director of Student Affairs Department, made an inspection tour of the examination committees for the first semester of the academic year 2022/2023 in the auditorium complex, examination halls, examination committees for the general program, the clinical pharmacy program, and examination committees for students of the Faculty of Pharmacy at Al-Ahlia University, to ensure the implementation of all directives related to exams, including the equipment of the committees, the provision of all services, the completion of all maintenance work for those, and their preparation by all means to prepare the atmosphere appropriate for students to take exams.
The tour took place on Monday 12/26/2022

God willing, the meeting of the Pharmaceutics Department Board of the Faculty of Pharmacy No. (510) will be held on Monday, January 2, 2023 AD, at ten in the morning
in the teaching hall on the third floor under the chairmanship of the Faculty to discuss the topics that we will inform you later.
Colorectal cancer (CRC) is the third highest major cause of morbidity and mortality worldwide. Hence, many strategies and approaches have been widely developed for cancer treatment. This work prepared and evaluated the antitumor activity of 5-Fluorouracil (5-Fu) loaded chromium nanoparticles (5-FuCrNPs). The green biosynthesis approach using Harpullia (H) pendula aqueous extract was used for CrNPs preparation, which was further loaded with 5-Fu. The prepared NPs were characterized for morphology using scanning and transmission electron microscopes (SEM and TEM). The results revealed the formation of uniform, mono-dispersive, and highly stable CrNPs with a mean size of 23 nm. Encapsulation of 5-Fu over CrNPs, with a higher drug loading efficiency, was successful with a mean size of 29 nm being produced. In addition, Fourier transform infrared (FTIR) and X-ray diffraction pattern (XRD) were also used for the investigation. The drug 5-Fu was adsorbed on the surface of biosynthesized CrNPs in order to overcome its clinical resistance and increase its activity against CRC cells. Box–Behnken Design (BBD) and response surface methodology (RSM) were used to characterize and optimize the formulation factors (5-Fu concentration, CrNP weight, and temperature). Furthermore, the antitumor activity of the prepared 5-FuCrNPs was tested against CRC cells (CACO-2). This in vitro antitumor study demonstrated that 5-Fu-loaded CrNPs markedly decreased the IC50 of 5-Fu and exerted more cytotoxicity at nearly all concentrations than 5-Fu alone. In conclusion, 5-FuCrNPs is a promising drug delivery system for the effective treatment of CRC.